chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 63.0
Sex: M
Vaccine: TDAP
Symptoms: Cough, Laboratory test normal, Pertussis, Productive cough, Pulmonary function test
Clinical narrative: Initial report was received from a consumer, who was also the patient, on 19 March 2012. A 64-year-old male patient had received a dose one injection in the left deltoid of ADACEL, sanofi pasteur Ltd. (lot number and route not reported) on 08 March 2011. In November of 2011, the patient developed a cough and by January of 2012 the cough became violent. The patient was treated with doxycycline for 10 days and the violent cough persisted. The patient saw a pulmonologist in March of 2012 and had a nasal swab that was negative. The patient was told her had "pertussis as all other diagnoses were ruled out." The patient also had pulmonary function test (PFTs). The patient's cough continued. The cough had lessened and continued to produce mucus. The patient had no illness at the time of vaccination. The patient had an allergy to amoxicillin and a medical history of celiac disease, thrombocytopenia, increased liver function test (LFT) and hypertension (HTN). The patient's outcome was not recovered. Documents held by sender: None.
Age: 11.0
Sex: F
Vaccine: HEPA, MNQ, TDAP
Symptoms: Dizziness, Fall, Pallor
Clinical narrative: When I gave the patient her 3rd vaccine (Menveo) she started swaying and then fell in my lap. I had given her Adacel (Tdap) and Havrix (Hep A) prior. She didn't completely pass out but she was able to set up in a chair and she had lost all color. She then started falling to the side but was still alert.
Age: 21.0
Sex: M
Vaccine: HEPA, MNQ, TDAP
Symptoms: Blood glucose, Hepatitis B antibody, Loss of consciousness, Unresponsive to stimuli
Clinical narrative: After patient had the immunizations TDAP, Hep A, and Menveo, the patient was fine but about a minute later her passed out and was unresponsive for about 10 seconds.
Age: 51.0
Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Local reaction, Pruritus, Skin warm, Swelling
Clinical narrative: Local reaction including redness, swelling, itching, and hot to the touch. Denies fever or SOB. Advised by RN to take Benadryl and ibuprofen, return to clinic if worsening.
Age: 6.0
Sex: F
Vaccine: FLU3, MMR
Symptoms: Rash
Clinical narrative: MILD REACTION, RASH ON FACE WITHOUT PRURITUS.
Age: 1.24
Sex: M
Vaccine: DTAP, HIBV, PNC13
Symptoms: Injection site erythema, Injection site haematoma, Injection site swelling
Clinical narrative: Localized swelling and redness on L thigh at injection site, minimal bruising first noticed 4 hours after injection.
Age: 11.0
Sex: F
Vaccine: TDAP
Symptoms: Clonus, Fall, Gaze palsy, Vomiting
Clinical narrative: Pt left room - at check out desk w/mom fell backwards - hit floor (linoleum) eyes rolled back in head/clonic movements. Gave O2 - monitored vitals. Once aroused - moved to pt room. Vomited and urinated. Vitals stable o2 sats 98% during episode. Sent to ER once stable.
Age: 5.0
Sex: M
Vaccine: DTAPIPV
Symptoms: Erythema, Injection site erythema
Clinical narrative: Within 48 hrs of KINRIX admin in patient's right thigh, a serpiginous area of redness developed approx 1 in from the injection site, ie, the injection site was not within this area. The redness gradually resolved over the next 3 days, with no sequelae.
Age: 1.07
Sex: M
Vaccine: HEPA, PNC, RV5, VARCEL
Symptoms: Blister, Pyrexia, Rash, Rash papular, Scab
Clinical narrative: Woke 1 day ago (3/21/12) red paps face, crusting and new lesions on feet some vesicular - fever 102 last night.
Age: 1.07
Sex: M
Vaccine: HEPA, PNC, RV5, VARCEL
Symptoms: Skin lesion
Clinical narrative: Woke 1 day ago (3/21/12) red paps face, crusting and new lesions on feet some vesicular - fever 102 last night.
Age: 52.0
Sex: F
Vaccine: TDAP
Symptoms: Hypoaesthesia, Injection site haematoma
Clinical narrative: Bruising at injection site, slight numbness below/adjacent to injection site (did not bleed at time of injection).
Age: 0.01
Sex: F
Vaccine: HEP
Symptoms: Inappropriate schedule of drug administration
Clinical narrative: None. Inadvertently received 2nd Hep B 2 days after first (before minimum interval).
Age: 1.05
Sex: F
Vaccine: HEPA, MMR, VARCEL
Symptoms: Blister, Herpangina, Oral papule, Pyrexia, Rash
Clinical narrative: Fever 3/26-3/28/12. Rash onset 3/26 PM body and mouth. Atypical rash with papules, tiny vesicles, mouth resembling herpangina.
Age: 1.05
Sex: F
Vaccine: HEPA, MMR, VARCEL
Symptoms: Rash generalised
Clinical narrative: Fever 3/26-3/28/12. Rash onset 3/26 PM body and mouth. Atypical rash with papules, tiny vesicles, mouth resembling herpangina.
Age: 0.16
Sex: M
Vaccine: DTAPIPVHIB, HEP, PNC13, RV5
Symptoms: Crying, Decreased appetite
Clinical narrative: Unconsolable crying, decreased appetite.
Age: 56.0
Sex: F
Vaccine: HEP
Symptoms: Arthropathy, Feeling abnormal, Hypoaesthesia, Muscle spasms, Paraesthesia
Clinical narrative: Client received #2 Hep B vaccination around 8:15am. C/o H/A throughout day, felt bad after work so went home and went to bed. Around 8:30pm woke and says had severe cramps in legs all the way down, and feet. Reports one time (R) hand turned inward with feet bilateral cramping, got so bad, with numbness & tingling. Reports 5 episodes of this within 2 hours.
Age: 0.17
Sex: M
Vaccine: DTAPIPVHIB, HEP, PNC13, RV5
Symptoms: Pulse absent, Sudden infant death syndrome, Unresponsive to stimuli
Clinical narrative: 2 month old found pulseless & unresponsive at home 7am 21 hrs after 2 month vaccines.
Age: 66.0
Sex: M
Vaccine: TDAP
Symptoms: Musculoskeletal pain, Rotator cuff syndrome
Clinical narrative: Had shoulder pain and soreness the day after injection, which continued. He saw provider on 3/28 for continued pain and was diagnosed with rotator cuff tendonitis. Will do ibuprofen, ice, heat and home care and if pain continues may have cortisone injection.
Age: 38.0
Sex: F
Vaccine: HEP
Symptoms: Dizziness, Malaise, Throat irritation
Clinical narrative: Pt voiced had scratchy throat, felt like passing out in early evning, at one am woke up didn't feel well like passing out again, went to ER, was admitted, doctors said it was due to shot but was cleared of all problems, my cardiac was fine, has some type of medical hx of BP lowing and like going to pass out, but said she could go ahead and continue with next schedule HBV. Instructed patient to return to clinic with doctors note/rx with medical clearance to receive HBV.
Age: 19.0
Sex: F
Vaccine: DTAP, HEPAB, IPV, MNQ
Symptoms: Burning sensation, Cough, Dyspnoea, Erythema, Throat irritation
Clinical narrative: Patient complained of "burning in her left shoulder at approximately 0940.  Upon inspection, the back of her shoulder had a large red area with 3 raised hives, she also complained of shortness of breath at that time.  At 0943 50mg Benadryl was administered to her right deltoid.  The patient then began complaining that her throat felt scratchy and she started coughing.  Patient was placed on 2L O2 via nasal canula and was given an Epipen injection to her right quad.  911 had been called and the patient was transported to the ER.
Age: 19.0
Sex: F
Vaccine: DTAP, HEPAB, IPV, MNQ
Symptoms: Urticaria
Clinical narrative: Patient complained of "burning in her left shoulder at approximately 0940.  Upon inspection, the back of her shoulder had a large red area with 3 raised hives, she also complained of shortness of breath at that time.  At 0943 50mg Benadryl was administered to her right deltoid.  The patient then began complaining that her throat felt scratchy and she started coughing.  Patient was placed on 2L O2 via nasal canula and was given an Epipen injection to her right quad.  911 had been called and the patient was transported to the ER.
Age: 47.0
Sex: F
Vaccine: TDAP
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Lymph node pain
Clinical narrative: WOKE IN THE MORNING WITH SWELLING, REDNESS, AND TENDERNESS IN RIGHT UPPER ARM. HAD SOME TENDERNESS IN LYMPHNODES.  TOOK TYLENOL.
Age: 0.36
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV1
Symptoms: Crying
Clinical narrative: CONSTANT CRYING X 4 DAYS PER MOM.
Age: 66.0
Sex: F
Vaccine: PPV
Symptoms: Injection site swelling, Injection site warmth, Nausea, Pyrexia
Clinical narrative: Hot, swollen arm around and distal to injection site, low grade fever, nausea.
Age: 0.18
Sex: M
Vaccine: DTAP
Symptoms: Abnormal behaviour, Decreased eye contact, Dyspnoea, Feeding disorder neonatal, Petit mal epilepsy
Clinical narrative: 3 seizures, multiple absence seizures for days afterward, strange & uncharacteristic behavior, labored breathing, less responsive, no eye contact, difficulty breastfeeding, screaming, sleep apnea.
Age: 0.18
Sex: M
Vaccine: DTAP
Symptoms: Screaming, Sleep apnoea syndrome, Slow response to stimuli
Clinical narrative: 3 seizures, multiple absence seizures for days afterward, strange & uncharacteristic behavior, labored breathing, less responsive, no eye contact, difficulty breastfeeding, screaming, sleep apnea.
Age: 11.0
Sex: F
Vaccine: MNQ, TDAP
Symptoms: Erythema, Oedema peripheral
Clinical narrative: Began getting swelling/redness in left arm on 3/29/12 per parents. Pt was able to move arm & ambulate.
Age: 13.0
Sex: M
Vaccine: HPV4, MNQ, HPV4, MNQ
Symptoms: Blood alcohol normal, Computerised tomogram normal, Disorientation, Full blood count normal, Gait disturbance
Clinical narrative: Patient experienced disorientation to person, time & place for 6 hours. Had difficulty walking & suffered a severe headache at onset of symptoms. Went to ER & CT scan & labs came back normal.
Age: 13.0
Sex: M
Vaccine: HPV4, MNQ, HPV4, MNQ
Symptoms: Headache, Laboratory test normal, Toxicologic test normal
Clinical narrative: Patient experienced disorientation to person, time & place for 6 hours. Had difficulty walking & suffered a severe headache at onset of symptoms. Went to ER & CT scan & labs came back normal.
Age: 13.0
Sex: M
Vaccine: HPV4, MNQ, HPV4, MNQ
Symptoms: Blood alcohol normal, Computerised tomogram normal, Disorientation, Full blood count normal, Headache
Clinical narrative: Patient experienced disorientation to person, time & place for 6 hours. Had difficulty walking & suffered a severe headache at onset of symptoms. Went to ER & CT scan & labs came back normal.
Age: 13.0
Sex: M
Vaccine: HPV4, MNQ, HPV4, MNQ
Symptoms: Impaired work ability, Laboratory test normal, Toxicologic test normal
Clinical narrative: Patient experienced disorientation to person, time & place for 6 hours. Had difficulty walking & suffered a severe headache at onset of symptoms. Went to ER & CT scan & labs came back normal.
Age: 12.0
Sex: M
Vaccine: HEPA, TDAP
Symptoms: Erythema, Induration
Clinical narrative: 6 x 6 cm redness, induration (L) arm.
Age: 0.17
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV5
Symptoms: Oral administration complication, Vomiting
Clinical narrative: Pt. vomited rotavirus vaccine immediately after administration in mouth. Pt. con't to vomit after 2 additional attempts to administer. Pt. wasn't able to even swallow any of the vaccine. Pt. was well at the time of admin.
Age: 31.0
Sex: F
Vaccine: TDAP
Symptoms: Abdominal discomfort, Asthenia, Chills, Nausea, Pyrexia
Clinical narrative: Fever, chills, felt like throwing up (but did not), very weak, upset stomach.
Age: 0.17
Sex: F
Vaccine: HEP
Symptoms: Choking, Cough, Decreased appetite, Diet refusal, Gastrooesophageal reflux disease
Clinical narrative: 99.6 fever for about 2 weeks. She stopped wanting to eat about 3 days later and got bad reflux with coughing, sneezing, choking, gagging and spitting up. Refusal to eat and long periods of sleep.
Age: 0.17
Sex: F
Vaccine: HEP
Symptoms: Hypersomnia, Infantile spitting up, Pyrexia, Retching, Sneezing
Clinical narrative: 99.6 fever for about 2 weeks. She stopped wanting to eat about 3 days later and got bad reflux with coughing, sneezing, choking, gagging and spitting up. Refusal to eat and long periods of sleep.
Age: 24.0
Sex: M
Vaccine: SMALL
Symptoms: Local reaction
Clinical narrative: Local reaction, no fever, no rash.
Age: 52.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site haematoma, Injection site pain, Injection site warmth
Clinical narrative: Briusing at injection site, day 2. Redness Size of baseball, Bruising approx. 2 inch diameter, day 3, mild soreness, area warm to touch.
Age: 62.0
Sex: F
Vaccine: VARZOS
Symptoms: Feeling abnormal
Clinical narrative: Patient stood up after vaccination and complained of feeling "not right, like the vaccine went right to her head". Patient sat back down, in 10 minutes she stated she was ok and left the pharmacy.
Age: 1.0
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Abdominal pain, Bacterial test negative, Diet refusal, Hand-foot-and-mouth disease, Irritability
Clinical narrative: She was running a 102 plus fever starting on the 29th for about 3 days and vomited on the morning of the 30th. Obvious Malaise, irritable, refused to eat.  4 weeks later she was irritable again with a high fever and was diagnosed with hand foot and mouth, though the only symptom was fever and ulcers in the back of throat. Since then for the past 11 months patient has developed cyclical fevers in which she will have 105 fevers for 5 to 7 days that result in a tonsillitis throat, but negative strep test and any other bacterial test.  During the fevers she refuses to eat, sometimes vomit and has complained of abdominal pain, but no diarrhea.  Her pediatrician is considering that she may have Pfapa.  The fevers have been shut down this month with 3 28 mg doses of prednisolone, but we expect it to return next month.
Age: 1.0
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Malaise, PFAPA syndrome, Pharyngeal ulceration, Pyrexia, Streptococcus test negative
Clinical narrative: She was running a 102 plus fever starting on the 29th for about 3 days and vomited on the morning of the 30th. Obvious Malaise, irritable, refused to eat.  4 weeks later she was irritable again with a high fever and was diagnosed with hand foot and mouth, though the only symptom was fever and ulcers in the back of throat. Since then for the past 11 months patient has developed cyclical fevers in which she will have 105 fevers for 5 to 7 days that result in a tonsillitis throat, but negative strep test and any other bacterial test.  During the fevers she refuses to eat, sometimes vomit and has complained of abdominal pain, but no diarrhea.  Her pediatrician is considering that she may have Pfapa.  The fevers have been shut down this month with 3 28 mg doses of prednisolone, but we expect it to return next month.
Age: 1.0
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Tonsillitis, Urine analysis normal, Vomiting
Clinical narrative: She was running a 102 plus fever starting on the 29th for about 3 days and vomited on the morning of the 30th. Obvious Malaise, irritable, refused to eat.  4 weeks later she was irritable again with a high fever and was diagnosed with hand foot and mouth, though the only symptom was fever and ulcers in the back of throat. Since then for the past 11 months patient has developed cyclical fevers in which she will have 105 fevers for 5 to 7 days that result in a tonsillitis throat, but negative strep test and any other bacterial test.  During the fevers she refuses to eat, sometimes vomit and has complained of abdominal pain, but no diarrhea.  Her pediatrician is considering that she may have Pfapa.  The fevers have been shut down this month with 3 28 mg doses of prednisolone, but we expect it to return next month.
Age: 1.0
Sex: F
Vaccine: FLUX(H1N1), HEPA, MMR, VARCEL
Symptoms: Asthenia, Balance disorder, Emotional distress, Fall, Insomnia
Clinical narrative: Child was lethargic and could not keep her balance -- she kept falling over and seemed weak. Later, a rash started on her trunk and spread to her face, head, neck, arms, and legs.  Child seemed to be in considerable pain and was inconsolable.  She had trouble sleeping.  The rash lasted for one week but other symptoms went away more quickly - in 4-6 days.
Age: 1.0
Sex: F
Vaccine: FLUX(H1N1), HEPA, MMR, VARCEL
Symptoms: Lethargy, Pain, Rash, Vaccination complication, Viral rash
Clinical narrative: Child was lethargic and could not keep her balance -- she kept falling over and seemed weak. Later, a rash started on her trunk and spread to her face, head, neck, arms, and legs.  Child seemed to be in considerable pain and was inconsolable.  She had trouble sleeping.  The rash lasted for one week but other symptoms went away more quickly - in 4-6 days.
Age: 79.0
Sex: F
Vaccine: FLU3
Symptoms: Immediate post-injection reaction, Pain in extremity, Skin warm
Clinical narrative: Right afterward, sore & warm arm. Pt. said this has never gone away. Waited 5 months to report event.
Age: 8.0
Sex: F
Vaccine: FLUN3
Symptoms: Body temperature increased, Dyspnoea, Immediate post-injection reaction, Urticaria, Wheezing
Clinical narrative: Patient recieved intranasal influenza vaccination at school and immediately developed hives on the face.  Ambulance was called and Benadryl 12.5mg was given as well as 0.3mg of epinephrine.  The patient reported trouble breathing/wheezing, but felt better following medication administration.  Patient denied any itching.  No facial swelling and hives had disappeared by time of arrival to ER.
Age: 13.0
Sex: M
Vaccine: FLUN3
Symptoms: Erythema, Rash
Clinical narrative: Patient presented to ER via ambulance following intranasal influenza immunization.  He developed rash and redness of the face following administration.  No difficulty swallowing, no swelling, no wheezing, or shortness of breath.  Patient was given Benadryl by the school nurse and 0.3mg of epinephrine via EpiPen.
Age: 5.0
Sex: M
Vaccine: MMR, MMR
Symptoms: Eyelid ptosis, Pyrexia
Clinical narrative: Information has been received from a registered nurse concerning a 5 year old male patient who on an unspecified date, was vaccinated with a dose of MMR II (lot number, dose and route not reported). Secondary suspect therapy included neomycin cream (it was unknown where the neomycin was applied). The registered nurse reported that she was told by the patient's mother that on an unspecified date, the child developed a severe allergic reaction for which the child was hospitalized. The name and location of the hospital where the child was hospitalised, and the dates of hospitalization were unknown. It was unknown if the allergic reaction occurred after the administration of MMR II (lot number, dose and route not reported) or after both the administration of the vaccine and application of the neomycin cream. At the time of the report the patient's outcome was unknown. Follow up information has been received from the physician concerning the student with no illness at the time of vaccination, no adverse events following prior vaccinations and with a history of diaper rash diagnosed as coxsackie in the ER but the mom believed it was due to NEOSPORIN use; who on 21-NOV-2011 at 17:58 hrs, was vaccinated subcutaneously with the second dose of MMR II (lot number 611014/0403A, dose not reported). There were no concomitant medications. On 09-JAN-2012, the physician received a call stating that the patient had a fever of 102.9. On 11-JAN-2012, per telephone call it was informed that the patient was feeling better (also reported as improved). On 20-JAN-2012 the patient presented with ptosis, fatigue and the patient was hospitalized, a CT scan of sinuses was performed and the patient was treated for sinusitis. On 31-DEC-2012 the patient presented again with a 4 day fever and fatigue and was hospitalized a second time, mentioned as fever unknown origin and drug rash. On an unspecified date, the patient underwent lab diagnostic tests which revealed high blood urea nitrogen (BUN). It was mentioned that the patient's mother saw a homeopathic practitioner who reported her that all the symptoms were related to MMR II. At the time of the report the patient had recovered from fever of unknown origin, sinusitis and fatigue and unknown for drug rash, ptosis and High BUN. Additional information has been requested.
Age: 5.0
Sex: M
Vaccine: MMR, MMR
Symptoms: Blood urea increased, Computerised tomogram abnormal, Drug eruption, Eyelid ptosis, Fatigue
Clinical narrative: Information has been received from a registered nurse concerning a 5 year old male patient who on an unspecified date, was vaccinated with a dose of MMR II (lot number, dose and route not reported). Secondary suspect therapy included neomycin cream (it was unknown where the neomycin was applied). The registered nurse reported that she was told by the patient's mother that on an unspecified date, the child developed a severe allergic reaction for which the child was hospitalized. The name and location of the hospital where the child was hospitalised, and the dates of hospitalization were unknown. It was unknown if the allergic reaction occurred after the administration of MMR II (lot number, dose and route not reported) or after both the administration of the vaccine and application of the neomycin cream. At the time of the report the patient's outcome was unknown. Follow up information has been received from the physician concerning the student with no illness at the time of vaccination, no adverse events following prior vaccinations and with a history of diaper rash diagnosed as coxsackie in the ER but the mom believed it was due to NEOSPORIN use; who on 21-NOV-2011 at 17:58 hrs, was vaccinated subcutaneously with the second dose of MMR II (lot number 611014/0403A, dose not reported). There were no concomitant medications. On 09-JAN-2012, the physician received a call stating that the patient had a fever of 102.9. On 11-JAN-2012, per telephone call it was informed that the patient was feeling better (also reported as improved). On 20-JAN-2012 the patient presented with ptosis, fatigue and the patient was hospitalized, a CT scan of sinuses was performed and the patient was treated for sinusitis. On 31-DEC-2012 the patient presented again with a 4 day fever and fatigue and was hospitalized a second time, mentioned as fever unknown origin and drug rash. On an unspecified date, the patient underwent lab diagnostic tests which revealed high blood urea nitrogen (BUN). It was mentioned that the patient's mother saw a homeopathic practitioner who reported her that all the symptoms were related to MMR II. At the time of the report the patient had recovered from fever of unknown origin, sinusitis and fatigue and unknown for drug rash, ptosis and High BUN. Additional information has been requested.
Age: 5.0
Sex: M
Vaccine: MMR, MMR
Symptoms: Hypersensitivity, Pyrexia, Sinusitis
Clinical narrative: Information has been received from a registered nurse concerning a 5 year old male patient who on an unspecified date, was vaccinated with a dose of MMR II (lot number, dose and route not reported). Secondary suspect therapy included neomycin cream (it was unknown where the neomycin was applied). The registered nurse reported that she was told by the patient's mother that on an unspecified date, the child developed a severe allergic reaction for which the child was hospitalized. The name and location of the hospital where the child was hospitalised, and the dates of hospitalization were unknown. It was unknown if the allergic reaction occurred after the administration of MMR II (lot number, dose and route not reported) or after both the administration of the vaccine and application of the neomycin cream. At the time of the report the patient's outcome was unknown. Follow up information has been received from the physician concerning the student with no illness at the time of vaccination, no adverse events following prior vaccinations and with a history of diaper rash diagnosed as coxsackie in the ER but the mom believed it was due to NEOSPORIN use; who on 21-NOV-2011 at 17:58 hrs, was vaccinated subcutaneously with the second dose of MMR II (lot number 611014/0403A, dose not reported). There were no concomitant medications. On 09-JAN-2012, the physician received a call stating that the patient had a fever of 102.9. On 11-JAN-2012, per telephone call it was informed that the patient was feeling better (also reported as improved). On 20-JAN-2012 the patient presented with ptosis, fatigue and the patient was hospitalized, a CT scan of sinuses was performed and the patient was treated for sinusitis. On 31-DEC-2012 the patient presented again with a 4 day fever and fatigue and was hospitalized a second time, mentioned as fever unknown origin and drug rash. On an unspecified date, the patient underwent lab diagnostic tests which revealed high blood urea nitrogen (BUN). It was mentioned that the patient's mother saw a homeopathic practitioner who reported her that all the symptoms were related to MMR II. At the time of the report the patient had recovered from fever of unknown origin, sinusitis and fatigue and unknown for drug rash, ptosis and High BUN. Additional information has been requested.
Age: 46.0
Sex: M
Vaccine: RAB, RAB
Symptoms: Dysgeusia, Feeling cold, Hyperhidrosis, Nervousness, Pallor
Clinical narrative: Pt states approx 5 hrs after rabies vaccine #2 he became dizzy, headache, feverish, chills, very dry mouth.
Age: 46.0
Sex: M
Vaccine: RAB, RAB
Symptoms: Chills, Dizziness, Dry mouth, Headache, Pyrexia
Clinical narrative: Pt states approx 5 hrs after rabies vaccine #2 he became dizzy, headache, feverish, chills, very dry mouth.
Age: 11.0
Sex: F
Vaccine: MNQ
Symptoms: Intensive care
Clinical narrative: 11 y/o female with Rett's syndrome, scoliosis, has had 2 recent spinal surgeries (1/31/12 anterior, 2/8/12 posterior).
Age: 4.0
Sex: M
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Hypersensitivity, Injection site erythema, Injection site swelling, Irritability, Pyrexia
Clinical narrative: Redness & swelling right arm & shoulder. Fever and fussiness.
Age: 0.34
Sex: F
Vaccine: RV5
Symptoms: Abdominal X-ray, Abdominal pain, Barium double contrast, Basophil count normal, Basophil percentage decreased
Clinical narrative: Information has been received from a physician concerning a baby patient who on an unknown dates was vaccinated with 3 doses of ROTATEQ (doses, routes and lot numbers not reported). The physician reported that a baby received 2 doses of ROTATEQ with a resolved episode of intussusception and then received the 3rd dose of ROTATEQ. It was unknown if the baby had intussusception prior to starting ROTATEQ series or if intussusception occurred after the 1st dose or 2nd dose of ROTATEQ. Follow up information has been received from a physician concerning a 26 week (reported as 6 month) old female patient with no illness at time of vaccination and no drug allergies who on 14-OCT-2011 and 19-DEC-2011 was vaccinated with a first and a second dose of ROTATEQ, (dose unknown), (Lot# 670243/0921AA known only for second dose) respectively. On 14-FEB-2012, the patient experienced intussusceptions with symptoms of abdominal pain, the patient was admitted for observation following reduction of an ileocecal in intussusception, one episode of bloody stools, no pain, no vomiting. Kidneys, Ureters, and Bladder examination on 14-FEB-2012 demonstrated a paucity of gas in colon, abdominal ultrasound on 14-FEB-2012 confirmed intussusception. On 13-FEB-2012 the patient underwent medical examination. Patient P was 143, CO2 sat 99, R 42, T 96.8, rotavirus antigen test was negative, abdominal USG confirmed intussusceptions. On 14 FEB-2012 the patient's glucose was 77, BUN 7, creatinine 0.2, calcium 10.5, sodium 138, potassium 5.0, chloride 105, CO2 23, WBC 20.62, RBC 4.12, HGB 10.3, HCT 31.5, MCV 76.5, MCH 25.0, MCHC 32.7, RDW 14, MPV 9.5, platelets 410, neutrophils 30, immature granulocyte 1, absolute neutrophils 6.12, absolute immature granulocyte 0.10, lymphocytes 61, monocytes 7, eosinophils 2, basophils 0, absolute lymphocytes 12.51, absolute monocytes 1.51, absolute eosinophils 0.34, absolute basophils 0.04. The patient was admitted to the hospital on 14-FEB-2012 (and spent there 1 day). The patient was treated with barium /air contrast enema. At the time of the report the patient status was recovered (recovery date was 15-FEB-2012). No further information is available.
Age: 0.34
Sex: F
Vaccine: RV5
Symptoms: Blood calcium normal, Blood chloride normal, Blood creatinine normal, Blood glucose normal, Blood potassium normal
Clinical narrative: Information has been received from a physician concerning a baby patient who on an unknown dates was vaccinated with 3 doses of ROTATEQ (doses, routes and lot numbers not reported). The physician reported that a baby received 2 doses of ROTATEQ with a resolved episode of intussusception and then received the 3rd dose of ROTATEQ. It was unknown if the baby had intussusception prior to starting ROTATEQ series or if intussusception occurred after the 1st dose or 2nd dose of ROTATEQ. Follow up information has been received from a physician concerning a 26 week (reported as 6 month) old female patient with no illness at time of vaccination and no drug allergies who on 14-OCT-2011 and 19-DEC-2011 was vaccinated with a first and a second dose of ROTATEQ, (dose unknown), (Lot# 670243/0921AA known only for second dose) respectively. On 14-FEB-2012, the patient experienced intussusceptions with symptoms of abdominal pain, the patient was admitted for observation following reduction of an ileocecal in intussusception, one episode of bloody stools, no pain, no vomiting. Kidneys, Ureters, and Bladder examination on 14-FEB-2012 demonstrated a paucity of gas in colon, abdominal ultrasound on 14-FEB-2012 confirmed intussusception. On 13-FEB-2012 the patient underwent medical examination. Patient P was 143, CO2 sat 99, R 42, T 96.8, rotavirus antigen test was negative, abdominal USG confirmed intussusceptions. On 14 FEB-2012 the patient's glucose was 77, BUN 7, creatinine 0.2, calcium 10.5, sodium 138, potassium 5.0, chloride 105, CO2 23, WBC 20.62, RBC 4.12, HGB 10.3, HCT 31.5, MCV 76.5, MCH 25.0, MCHC 32.7, RDW 14, MPV 9.5, platelets 410, neutrophils 30, immature granulocyte 1, absolute neutrophils 6.12, absolute immature granulocyte 0.10, lymphocytes 61, monocytes 7, eosinophils 2, basophils 0, absolute lymphocytes 12.51, absolute monocytes 1.51, absolute eosinophils 0.34, absolute basophils 0.04. The patient was admitted to the hospital on 14-FEB-2012 (and spent there 1 day). The patient was treated with barium /air contrast enema. At the time of the report the patient status was recovered (recovery date was 15-FEB-2012). No further information is available.
Age: 0.34
Sex: F
Vaccine: RV5
Symptoms: Blood sodium normal, Blood urea normal, Body temperature decreased, Carbon dioxide normal, Enema administration
Clinical narrative: Information has been received from a physician concerning a baby patient who on an unknown dates was vaccinated with 3 doses of ROTATEQ (doses, routes and lot numbers not reported). The physician reported that a baby received 2 doses of ROTATEQ with a resolved episode of intussusception and then received the 3rd dose of ROTATEQ. It was unknown if the baby had intussusception prior to starting ROTATEQ series or if intussusception occurred after the 1st dose or 2nd dose of ROTATEQ. Follow up information has been received from a physician concerning a 26 week (reported as 6 month) old female patient with no illness at time of vaccination and no drug allergies who on 14-OCT-2011 and 19-DEC-2011 was vaccinated with a first and a second dose of ROTATEQ, (dose unknown), (Lot# 670243/0921AA known only for second dose) respectively. On 14-FEB-2012, the patient experienced intussusceptions with symptoms of abdominal pain, the patient was admitted for observation following reduction of an ileocecal in intussusception, one episode of bloody stools, no pain, no vomiting. Kidneys, Ureters, and Bladder examination on 14-FEB-2012 demonstrated a paucity of gas in colon, abdominal ultrasound on 14-FEB-2012 confirmed intussusception. On 13-FEB-2012 the patient underwent medical examination. Patient P was 143, CO2 sat 99, R 42, T 96.8, rotavirus antigen test was negative, abdominal USG confirmed intussusceptions. On 14 FEB-2012 the patient's glucose was 77, BUN 7, creatinine 0.2, calcium 10.5, sodium 138, potassium 5.0, chloride 105, CO2 23, WBC 20.62, RBC 4.12, HGB 10.3, HCT 31.5, MCV 76.5, MCH 25.0, MCHC 32.7, RDW 14, MPV 9.5, platelets 410, neutrophils 30, immature granulocyte 1, absolute neutrophils 6.12, absolute immature granulocyte 0.10, lymphocytes 61, monocytes 7, eosinophils 2, basophils 0, absolute lymphocytes 12.51, absolute monocytes 1.51, absolute eosinophils 0.34, absolute basophils 0.04. The patient was admitted to the hospital on 14-FEB-2012 (and spent there 1 day). The patient was treated with barium /air contrast enema. At the time of the report the patient status was recovered (recovery date was 15-FEB-2012). No further information is available.
Age: 0.34
Sex: F
Vaccine: RV5
Symptoms: Eosinophil count normal, Eosinophil percentage, Flatulence, Haematochezia, Haematocrit normal
Clinical narrative: Information has been received from a physician concerning a baby patient who on an unknown dates was vaccinated with 3 doses of ROTATEQ (doses, routes and lot numbers not reported). The physician reported that a baby received 2 doses of ROTATEQ with a resolved episode of intussusception and then received the 3rd dose of ROTATEQ. It was unknown if the baby had intussusception prior to starting ROTATEQ series or if intussusception occurred after the 1st dose or 2nd dose of ROTATEQ. Follow up information has been received from a physician concerning a 26 week (reported as 6 month) old female patient with no illness at time of vaccination and no drug allergies who on 14-OCT-2011 and 19-DEC-2011 was vaccinated with a first and a second dose of ROTATEQ, (dose unknown), (Lot# 670243/0921AA known only for second dose) respectively. On 14-FEB-2012, the patient experienced intussusceptions with symptoms of abdominal pain, the patient was admitted for observation following reduction of an ileocecal in intussusception, one episode of bloody stools, no pain, no vomiting. Kidneys, Ureters, and Bladder examination on 14-FEB-2012 demonstrated a paucity of gas in colon, abdominal ultrasound on 14-FEB-2012 confirmed intussusception. On 13-FEB-2012 the patient underwent medical examination. Patient P was 143, CO2 sat 99, R 42, T 96.8, rotavirus antigen test was negative, abdominal USG confirmed intussusceptions. On 14 FEB-2012 the patient's glucose was 77, BUN 7, creatinine 0.2, calcium 10.5, sodium 138, potassium 5.0, chloride 105, CO2 23, WBC 20.62, RBC 4.12, HGB 10.3, HCT 31.5, MCV 76.5, MCH 25.0, MCHC 32.7, RDW 14, MPV 9.5, platelets 410, neutrophils 30, immature granulocyte 1, absolute neutrophils 6.12, absolute immature granulocyte 0.10, lymphocytes 61, monocytes 7, eosinophils 2, basophils 0, absolute lymphocytes 12.51, absolute monocytes 1.51, absolute eosinophils 0.34, absolute basophils 0.04. The patient was admitted to the hospital on 14-FEB-2012 (and spent there 1 day). The patient was treated with barium /air contrast enema. At the time of the report the patient status was recovered (recovery date was 15-FEB-2012). No further information is available.
Age: 0.34
Sex: F
Vaccine: RV5
Symptoms: Haemoglobin normal, Intussusception, Lymphocyte count increased, Lymphocyte percentage increased, Mean cell haemoglobin concentration normal
Clinical narrative: Information has been received from a physician concerning a baby patient who on an unknown dates was vaccinated with 3 doses of ROTATEQ (doses, routes and lot numbers not reported). The physician reported that a baby received 2 doses of ROTATEQ with a resolved episode of intussusception and then received the 3rd dose of ROTATEQ. It was unknown if the baby had intussusception prior to starting ROTATEQ series or if intussusception occurred after the 1st dose or 2nd dose of ROTATEQ. Follow up information has been received from a physician concerning a 26 week (reported as 6 month) old female patient with no illness at time of vaccination and no drug allergies who on 14-OCT-2011 and 19-DEC-2011 was vaccinated with a first and a second dose of ROTATEQ, (dose unknown), (Lot# 670243/0921AA known only for second dose) respectively. On 14-FEB-2012, the patient experienced intussusceptions with symptoms of abdominal pain, the patient was admitted for observation following reduction of an ileocecal in intussusception, one episode of bloody stools, no pain, no vomiting. Kidneys, Ureters, and Bladder examination on 14-FEB-2012 demonstrated a paucity of gas in colon, abdominal ultrasound on 14-FEB-2012 confirmed intussusception. On 13-FEB-2012 the patient underwent medical examination. Patient P was 143, CO2 sat 99, R 42, T 96.8, rotavirus antigen test was negative, abdominal USG confirmed intussusceptions. On 14 FEB-2012 the patient's glucose was 77, BUN 7, creatinine 0.2, calcium 10.5, sodium 138, potassium 5.0, chloride 105, CO2 23, WBC 20.62, RBC 4.12, HGB 10.3, HCT 31.5, MCV 76.5, MCH 25.0, MCHC 32.7, RDW 14, MPV 9.5, platelets 410, neutrophils 30, immature granulocyte 1, absolute neutrophils 6.12, absolute immature granulocyte 0.10, lymphocytes 61, monocytes 7, eosinophils 2, basophils 0, absolute lymphocytes 12.51, absolute monocytes 1.51, absolute eosinophils 0.34, absolute basophils 0.04. The patient was admitted to the hospital on 14-FEB-2012 (and spent there 1 day). The patient was treated with barium /air contrast enema. At the time of the report the patient status was recovered (recovery date was 15-FEB-2012). No further information is available.
Age: 0.34
Sex: F
Vaccine: RV5
Symptoms: Mean cell haemoglobin decreased, Mean cell volume decreased, Mean platelet volume normal, Monocyte count increased, Monocyte percentage
Clinical narrative: Information has been received from a physician concerning a baby patient who on an unknown dates was vaccinated with 3 doses of ROTATEQ (doses, routes and lot numbers not reported). The physician reported that a baby received 2 doses of ROTATEQ with a resolved episode of intussusception and then received the 3rd dose of ROTATEQ. It was unknown if the baby had intussusception prior to starting ROTATEQ series or if intussusception occurred after the 1st dose or 2nd dose of ROTATEQ. Follow up information has been received from a physician concerning a 26 week (reported as 6 month) old female patient with no illness at time of vaccination and no drug allergies who on 14-OCT-2011 and 19-DEC-2011 was vaccinated with a first and a second dose of ROTATEQ, (dose unknown), (Lot# 670243/0921AA known only for second dose) respectively. On 14-FEB-2012, the patient experienced intussusceptions with symptoms of abdominal pain, the patient was admitted for observation following reduction of an ileocecal in intussusception, one episode of bloody stools, no pain, no vomiting. Kidneys, Ureters, and Bladder examination on 14-FEB-2012 demonstrated a paucity of gas in colon, abdominal ultrasound on 14-FEB-2012 confirmed intussusception. On 13-FEB-2012 the patient underwent medical examination. Patient P was 143, CO2 sat 99, R 42, T 96.8, rotavirus antigen test was negative, abdominal USG confirmed intussusceptions. On 14 FEB-2012 the patient's glucose was 77, BUN 7, creatinine 0.2, calcium 10.5, sodium 138, potassium 5.0, chloride 105, CO2 23, WBC 20.62, RBC 4.12, HGB 10.3, HCT 31.5, MCV 76.5, MCH 25.0, MCHC 32.7, RDW 14, MPV 9.5, platelets 410, neutrophils 30, immature granulocyte 1, absolute neutrophils 6.12, absolute immature granulocyte 0.10, lymphocytes 61, monocytes 7, eosinophils 2, basophils 0, absolute lymphocytes 12.51, absolute monocytes 1.51, absolute eosinophils 0.34, absolute basophils 0.04. The patient was admitted to the hospital on 14-FEB-2012 (and spent there 1 day). The patient was treated with barium /air contrast enema. At the time of the report the patient status was recovered (recovery date was 15-FEB-2012). No further information is available.
Age: 0.34
Sex: F
Vaccine: RV5
Symptoms: Neutrophil count decreased, Neutrophil percentage decreased, Platelet count normal, Red blood cell count normal, Red cell distribution width normal
Clinical narrative: Information has been received from a physician concerning a baby patient who on an unknown dates was vaccinated with 3 doses of ROTATEQ (doses, routes and lot numbers not reported). The physician reported that a baby received 2 doses of ROTATEQ with a resolved episode of intussusception and then received the 3rd dose of ROTATEQ. It was unknown if the baby had intussusception prior to starting ROTATEQ series or if intussusception occurred after the 1st dose or 2nd dose of ROTATEQ. Follow up information has been received from a physician concerning a 26 week (reported as 6 month) old female patient with no illness at time of vaccination and no drug allergies who on 14-OCT-2011 and 19-DEC-2011 was vaccinated with a first and a second dose of ROTATEQ, (dose unknown), (Lot# 670243/0921AA known only for second dose) respectively. On 14-FEB-2012, the patient experienced intussusceptions with symptoms of abdominal pain, the patient was admitted for observation following reduction of an ileocecal in intussusception, one episode of bloody stools, no pain, no vomiting. Kidneys, Ureters, and Bladder examination on 14-FEB-2012 demonstrated a paucity of gas in colon, abdominal ultrasound on 14-FEB-2012 confirmed intussusception. On 13-FEB-2012 the patient underwent medical examination. Patient P was 143, CO2 sat 99, R 42, T 96.8, rotavirus antigen test was negative, abdominal USG confirmed intussusceptions. On 14 FEB-2012 the patient's glucose was 77, BUN 7, creatinine 0.2, calcium 10.5, sodium 138, potassium 5.0, chloride 105, CO2 23, WBC 20.62, RBC 4.12, HGB 10.3, HCT 31.5, MCV 76.5, MCH 25.0, MCHC 32.7, RDW 14, MPV 9.5, platelets 410, neutrophils 30, immature granulocyte 1, absolute neutrophils 6.12, absolute immature granulocyte 0.10, lymphocytes 61, monocytes 7, eosinophils 2, basophils 0, absolute lymphocytes 12.51, absolute monocytes 1.51, absolute eosinophils 0.34, absolute basophils 0.04. The patient was admitted to the hospital on 14-FEB-2012 (and spent there 1 day). The patient was treated with barium /air contrast enema. At the time of the report the patient status was recovered (recovery date was 15-FEB-2012). No further information is available.
Age: 0.34
Sex: F
Vaccine: RV5
Symptoms: Rotavirus test negative, Small intestinal intussusception reduction, Ultrasound abdomen abnormal, White blood cell count increased, White blood cell morphology abnormal
Clinical narrative: Information has been received from a physician concerning a baby patient who on an unknown dates was vaccinated with 3 doses of ROTATEQ (doses, routes and lot numbers not reported). The physician reported that a baby received 2 doses of ROTATEQ with a resolved episode of intussusception and then received the 3rd dose of ROTATEQ. It was unknown if the baby had intussusception prior to starting ROTATEQ series or if intussusception occurred after the 1st dose or 2nd dose of ROTATEQ. Follow up information has been received from a physician concerning a 26 week (reported as 6 month) old female patient with no illness at time of vaccination and no drug allergies who on 14-OCT-2011 and 19-DEC-2011 was vaccinated with a first and a second dose of ROTATEQ, (dose unknown), (Lot# 670243/0921AA known only for second dose) respectively. On 14-FEB-2012, the patient experienced intussusceptions with symptoms of abdominal pain, the patient was admitted for observation following reduction of an ileocecal in intussusception, one episode of bloody stools, no pain, no vomiting. Kidneys, Ureters, and Bladder examination on 14-FEB-2012 demonstrated a paucity of gas in colon, abdominal ultrasound on 14-FEB-2012 confirmed intussusception. On 13-FEB-2012 the patient underwent medical examination. Patient P was 143, CO2 sat 99, R 42, T 96.8, rotavirus antigen test was negative, abdominal USG confirmed intussusceptions. On 14 FEB-2012 the patient's glucose was 77, BUN 7, creatinine 0.2, calcium 10.5, sodium 138, potassium 5.0, chloride 105, CO2 23, WBC 20.62, RBC 4.12, HGB 10.3, HCT 31.5, MCV 76.5, MCH 25.0, MCHC 32.7, RDW 14, MPV 9.5, platelets 410, neutrophils 30, immature granulocyte 1, absolute neutrophils 6.12, absolute immature granulocyte 0.10, lymphocytes 61, monocytes 7, eosinophils 2, basophils 0, absolute lymphocytes 12.51, absolute monocytes 1.51, absolute eosinophils 0.34, absolute basophils 0.04. The patient was admitted to the hospital on 14-FEB-2012 (and spent there 1 day). The patient was treated with barium /air contrast enema. At the time of the report the patient status was recovered (recovery date was 15-FEB-2012). No further information is available.
Age: 69.0
Sex: M
Vaccine: FLU3
Symptoms: Injection site reaction, Mobility decreased, Musculoskeletal pain, Myalgia
Clinical narrative: Muscle pain in shoulder (L) from point of injection. After 1 week pain traveled to other shoulder to point couldn't lift arm. Constant pain since then.
Age: 4.0
Sex: F
Vaccine: DTAPIPV, HEPA, MMR, VARCEL
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth
Clinical narrative: Left deltoid slightly swollen, warm to touch. Redness 4 x 4 1/2 inches. Per mother pt. scratching her arms. Ice pack applied & reminded mother to continue rubbing area & apply ice pack for 10-15 min every 2-3 hours to come back if no changes.
Age: 25.0
Sex: F
Vaccine: VARCEL
Symptoms: Erythema, Oedema peripheral, Pruritus
Clinical narrative: Pt. developed a large area of redness, itching and swelling on RUE, following her second of (2) Varicella vaccines, given on 3/28/12.
Age: 49.0
Sex: F
Vaccine: HEPAB
Symptoms: Injection site pruritus, Injection site reaction, Muscle swelling
Clinical narrative: Itching and muscle swelling at injection site; still mild swelling on date of report (4/2/12).
Age: 4.0
Sex: F
Vaccine: DTAPIPV, MMRV
Symptoms: Injection site erythema, Injection site warmth
Clinical narrative: 3X3 area of redness and warmth to area pt received Kinrix vaccine.
Age: 33.0
Sex: M
Vaccine: TD
Symptoms: Injection site discomfort
Clinical narrative: Discomfort in Left upper arm when applying pressure. No redness or swelling. Patient was evaluated at outside clinic.
Age: 78.0
Sex: M
Vaccine: MNQ
Symptoms: Drug administered to patient of inappropriate age, No adverse event
Clinical narrative: Given to Patient over 55.  No adverse events.
Age: 1.02
Sex: M
Vaccine: HEPA, HIBV, MMR, PNC13, VARCEL
Symptoms: Injection site erythema, Urticaria
Clinical narrative: Patient was sitting in waiting room when tech noticed left leg had bright redness that was going down to the knee cap.  Tech also saw hives on the left side of the stomach and upper back.  Patient was not in distress or having trouble breathing.  Patient was brought back to the exam room and was seen by the on-call provider.  1 teaspoon of 12.5 mg oral diphenhydramine was given and vitals were monitored for 30 minutes.  Referral to allergy doctor placed.
Age: 8.0
Sex: F
Vaccine: FLUN3
Symptoms: Dyspnoea, Hypersensitivity, Pruritus
Clinical narrative: Patient presented to the ER following allergic reaction to intranasal influenza vaccination.  Patient developed itching over abdomen and arms, but no real rash.  School nurse gave the patient two doses of liquid Benadryl 12.5mg each.  The child fle t some difficulty breathing, but no difficulty swallowing.
Age: 0.53
Sex: F
Vaccine: DTAPIPVHIB, HEP, PNC13, RV5, DTAPIPVHIB, HEP, PNC13, RV5
Symptoms: Barium enema, Enema administration, Intussusception
Clinical narrative: Intussusception with recurrence x1.
Age: 0.53
Sex: F
Vaccine: DTAPIPVHIB, HEP, PNC13, RV5, DTAPIPVHIB, HEP, PNC13, RV5
Symptoms: Abdominal X-ray, Abdominal pain, Barium enema abnormal, Cold sweat, Cough
Clinical narrative: Intussusception with recurrence x1.
Age: 0.53
Sex: F
Vaccine: DTAPIPVHIB, HEP, PNC13, RV5, DTAPIPVHIB, HEP, PNC13, RV5
Symptoms: Crying, Decreased appetite, Diarrhoea, Enema administration, Gastroenteritis
Clinical narrative: Intussusception with recurrence x1.
Age: 0.53
Sex: F
Vaccine: DTAPIPVHIB, HEP, PNC13, RV5, DTAPIPVHIB, HEP, PNC13, RV5
Symptoms: Hypophagia, Hypotonia, Intussusception, Irritability, Lethargy
Clinical narrative: Intussusception with recurrence x1.
Age: 0.53
Sex: F
Vaccine: DTAPIPVHIB, HEP, PNC13, RV5, DTAPIPVHIB, HEP, PNC13, RV5
Symptoms: Opisthotonus, Pallor, Pyrexia, Retching, Rhinitis
Clinical narrative: Intussusception with recurrence x1.
Age: 0.53
Sex: F
Vaccine: DTAPIPVHIB, HEP, PNC13, RV5, DTAPIPVHIB, HEP, PNC13, RV5
Symptoms: Somnolence, Ultrasound abdomen abnormal, Viral upper respiratory tract infection, Vomiting
Clinical narrative: Intussusception with recurrence x1.
Age: 4.0
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC13
Symptoms: Crying, Pyrexia
Clinical narrative: Excessive Crying. Fever of 103.